F1-based mRNA-LNP

N/A

Report date: 2026/05/13 09:11:44

Base Information

Drug NameF1-based mRNA-LNP

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionAnti-F1 capsule antigenImmunostimulants

TargetsF1 capsule antigen

Therapy Area/IndicationsPlague

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTel Aviv University

China Registration ClassN/A

Develop Information

Active CompaniesTel Aviv University

Inactive CompaniesN/A

Active IndicationsPlague

Inactive IndicationsN/A

Other Information

ATC CodeN/A